About
Dr. Aaron Royston has served as an Achieve Life Sciences director since 2026 and serves on the Nominating and Governance Committee. He has been a managing partner at venBio Partners, a life-sciences investment firm, since April 2020 and has been with the firm since 2015; he previously was a Senior Associate at Vivo Capital and a consultant at Bain & Company. Dr. Royston has served on the boards of RayzeBio, Ventyx Biosciences, Akero Therapeutics and VYNE Therapeutics, as well as several private companies. He received a B.S. in biological sciences from Duke University and an M.D. and M.B.A. from the University of Pennsylvania.
Roles
Achieve Life Sciences, Inc.
Director · Current role
2026–present
venBio Partners
Managing Partner · With the firm since 2015
2020 - present
Vivo Capital
Senior Associate
2014 - 2015
Bain & Company, Inc.
Consultant
2013 - 2014
External Roles
RayzeBio
Director
2020 - 2023
Ventyx Biosciences, Inc.
Director
2021 - 2023
Akero Therapeutics, Inc.
Director
2018 - 2019
VYNE Therapeutics Inc.
Director
2017 - 2019
Also at Achieve Life Sciences, Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.